Suzanne de la Monte, M.D., M.P.H.
de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wiedmann M, Carter JJ, Lahouse SA, Califano S, Maeda T, Ueno T, D’Errico A, Trevisani F, Wands JR.
Aspartyl-(asparaginyl)-b-hydroxylase regulates hepatocellular carcinoma invasiveness. J of Hepatology 2006: 44 (in press).
Selected Publications:
de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wiedmann M, Carter JJ, Lahouse SA, Califano S, Maeda T, Ueno T, D’Errico A, Trevisani F, Wands JR.
Aspartyl-(asparaginyl)-b-hydroxylase regulates hepatocellular carcinoma invasiveness. J of Hepatology 2006: 44 (in press).
Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM.
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis. 2005 Dec;8(3):247-68.
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis. 2005 Dec;8(3):247-68.
de la Monte SM, Xu XJ, Wands JR.
Ethanol inhibits insulin expression and actions in the developing brain. Cell Mol Life Sci. 2005 May;62(10):1131-45.
Ethanol inhibits insulin expression and actions in the developing brain. Cell Mol Life Sci. 2005 May;62(10):1131-45.
Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM.
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? J Alzheimers Dis. 2005 Feb;7(1):63-80.
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? J Alzheimers Dis. 2005 Feb;7(1):63-80.
de la Monte SM, Wands JR.
Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis. 2005 Feb;7(1):45-61.
Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis. 2005 Feb;7(1):45-61.
Maeda T, Taguchi K, Aishima S, Shimada M, Hintz D, Larusso N, Gores G, Tsuneyoshi M, Sugimachi K, Wands JR, de la Monte SM.
Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma. Cancer Detect Prev. 2004;28(5):313-8.
Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma. Cancer Detect Prev. 2004;28(5):313-8.
Back to Faculty List
Suzanne de la Monte, M.D., M.P.H.
Associate Professor of Pathology and Medicine
Address:
Pierre Galletti Laboratories
55 Claverick Street, 4th Floor Providence, RI 02903 phone: 401-444-7441 fax: 401-444-2939 E-mail: Suzanne_DeLaMonte_MD@Brown.edu | |
Clinical Interests:
Neuropathology and general pathology.
Research Interests:
I
am interested in the molecular mechanisms of
programmed cell death as well as the role of aspartyl
(asparaginyl)-beta-hydroxylase (AAH) in cell
motility and invasiveness of tumor cells as well as
neuronal cells. In addition, our studies focus on
growth factor signaling through IRS-1 and the role of this
pathway in oncogenesis.
Expression of AAH in Pancreatic Cancer  |
